Provided by Tiger Trade Technology Pte. Ltd.

Imunon, Inc.

2.72
+0.01000.37%
Post-market: 2.720.00000.00%19:17 EDT
Volume:78.59K
Turnover:218.92K
Market Cap:9.25M
PE:-0.28
High:2.92
Open:2.80
Low:2.64
Close:2.71
52wk High:41.22
52wk Low:2.52
Shares:3.40M
Float Shares:3.37M
Volume Ratio:0.11
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-9.5449
EPS(LYR):-21.1044
ROE:-233.50%
ROA:-77.72%
PB:2.27
PE(LYR):-0.13

Loading ...

Imunon Inc expected to post a loss of $1.17 a share - Earnings Preview

Reuters
·
Mar 27

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 27

BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings

Reuters
·
Mar 26

Imunon announces final clinical data from OVATION 2 clinical trial

TIPRANKS
·
Mar 25

Imunon: Patients Treated With Parp Inhibitor Therapy With Imnn-001 & Standard of Care Chemotherapy Showed Median Increase in Os of 24.2 Mnths

THOMSON REUTERS
·
Mar 25

Imunon Reports Updated Phase 2 Data Showing Continued Improvement in Median Overall Survival With Imnn-001 in Women With Newly Diagnosed Advanced Ovarian Cancer

THOMSON REUTERS
·
Mar 25

Imunon: Rise in Median Overall Survival Among Women Treated With Imnn-001 in Ovation 2 Trial Rose From 11.1 Mnths to 14.7 Mnths

THOMSON REUTERS
·
Mar 25

Imunon reports Phase 2 OVATION 2 data; median overall survival rises by 14.7 months with IMNN-001 in newly diagnosed advanced ovarian cancer

Reuters
·
Mar 25

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 25

Imunon to host year-end 2025 financial results conference call

Reuters
·
Mar 24

Imunon files prospectus supplement for USD 7 million at-the-market common stock offering

Reuters
·
Mar 24

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 23

Imunon Inc expected to post a loss of $1.17 a share - Earnings Preview

Reuters
·
Mar 20

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 20

Imunon Inc expected to post a loss of $1.17 a share - Earnings Preview

Reuters
·
Feb 23

Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Oncolytics Biotech (ONCY) and Imunon (IMNN)

TIPRANKS
·
Feb 06

BUZZ-U.S. STOCKS ON THE MOVE-OneSpaWorld, IMUNON, Cigna

Reuters
·
Feb 05

BUZZ-IMUNON rises on plan to shift resources to ovarian cancer therapy

Reuters
·
Feb 05

BRIEF-Imunon Sharpens Focus On Its Promising Pivotal Phase 3 Ovarian Cancer Study

Reuters
·
Feb 05

Imunon announces reorganization to eliminate headcount for Phase 3 trial

TIPRANKS
·
Feb 05